Modus Operandi

» cancer, gene silencing and electron microscopy

Most Recent

image: Targeting Tregs Halts Cancer’s Immune Helpers

Targeting Tregs Halts Cancer’s Immune Helpers

By | April 1, 2017

New monoclonal antibodies kill both cancer-promoting immunosuppressive cells and tumor cells in culture.

0 Comments

image: Tumor-Shrinking Triple-Helices

Tumor-Shrinking Triple-Helices

By | April 1, 2016

A braided structure and some adhesive hydrogel make therapeutic microRNAs both stable and sticky.

0 Comments

image: Bursting Cancer’s Bubble

Bursting Cancer’s Bubble

By | April 1, 2015

Scientists make oxygen-filled microbubbles designed to increase tumor sensitivity to radiation.

3 Comments

image: Exit Strategy

Exit Strategy

By | January 1, 2014

Scientists come up with a better way to watch cells leave blood vessels.

0 Comments

image: BRET Meets FRET

BRET Meets FRET

By | May 1, 2013

Scientists create biocompatible, self-luminescing nanoparticles for in vivo imaging.

0 Comments

image: Milling Magic

Milling Magic

By | August 1, 2012

Ion beams carve slices in frozen cells, giving biologists an interior view.

1 Comment

image: Dynamic Delivery

Dynamic Delivery

By | July 1, 2012

Microscopic sponges made entirely of RNA enable efficient gene silencing.

0 Comments

image: Bubble Vision

Bubble Vision

By | May 1, 2012

Turning a liability into an asset, cryo-electron microscopists exploit an artifact to probe protein structure.

0 Comments

image: A Brighter Beacon

A Brighter Beacon

By | April 1, 2012

A novel liquid laser set-up can detect single nucleotide mutations in a cancer gene.

0 Comments

image: Delivering Silence

Delivering Silence

By | March 1, 2012

Using RNA viruses to silence genes could optimize tissue targeting while reducing toxicity.

0 Comments

Popular Now

  1. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. Consilience, Episode 3: Cancer, Obscured
  4. A History of Screening for Natural Products to Fight Cancer
AAAS